⏳ Final hours! Save up to 60% OFF InvestingProCLAIM SALE

Dollar Edges Higher on Vaccine Woes; Sterling Weakens

Published 14/10/2020, 07:47
© Reuters.
EUR/USD
-
GBP/USD
-
USD/JPY
-
LLY
-
JNJ
-

By Peter Nurse

Investing.com - The dollar edged higher in early European trade Wednesday, holding on to recent gains following doubts about how quickly a Covid-19 vaccine will come to the market, prompting a more risk averse trading environment.

At 2:50 AM ET (0650 GMT), the Dollar Index, which tracks the greenback against a basket of six other currencies, was up marginally at 93.567, retaining recent gains after hitting a three-week low of 92.997 on Friday. 

Elsewhere, EUR/USD was down 0.1% at 1.1744, while USD/JPY was up 0.1% at 105.50.

Risk appetite has weakened after Eli Lilly (NYSE:LLY) placed its coronavirus antibody test on hold due to potential safety concerns, less than a day after Johnson & Johnson (NYSE:JNJ) paused its Covid-19 vaccine trial because of a participant’s unexplained illness.

The coronavirus continues to tighten its grip on the Western world, with Europe, in particular, hard hit by a second wave. Many countries are now widening restrictions to try to regain a grip on the pandemic. 

That said, the recent losses in equity markets have been pretty small and currency moves are likely to be subdued as the U.S. presidential election looms on Nov. 3.

“Overall, markets may still be inclined to look at the glass half full as they retain some hope around U.S. fiscal stimulus and Joe Biden’s consolidated lead in the polls which lowers the perceived risk of a contested election,” said analysts at ING, in a research note.

Elsewhere, GBP/USD traded 0.2% lower at 1.2906, extending declines after U.K. Prime Minister Boris Johnson repeated his threat to abandon negotiations with the EU on relations between the two after the end of the Brexit transition phase.

Johnson’s self-imposed Oct. 15 deadline drawing near and there are few signs of an agreement being reached.

The European Union would prefer to have a Brexit deal, but it is ready in case no agreement can be reached, the Commissioner for the EU's single market, Thierry Breton, said late Tuesday.

EU leaders are holding a summit in Brussels on Thursday and Friday to assess progress. 

Later Wednesday, the International Monetary Fund will publish its latest Fiscal Monitor, which will track the likely path of budget deficits next year as they come to terms with the pandemic's after-effects. The IMF on Tuesday had forecast a 4.3% contraction for the U.S. economy this year, and an 8.3% drop in Eurozone GDP.

 

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.